Belimumab With Rituximab for Primary Membranous Nephropathy

NCT03949855 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

58

Enrollment

NIH

Sponsor class

Conditions

Membranous Nephropathy
Nephrotic Syndrome

Interventions

DRUG: Belimumab
DRUG: Placebo for Belimumab
DRUG: Rituximab

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]